Back

Caspian’s KO-7246 shows durable diabetes benefits in preclinical models

Verifying
  • Caspian and Kura reported preclinical KO-7246 data across Type 1 and Type 2 diabetes models.
  • 3.4-fold increase in β-cell mass was observed in a mouse Type 2 diabetes model.
  • KO-7246 data were presented at the 62nd EASD Annual Meeting in Milan.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.